Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Surya Vishva Teja Jangolla, M.B.,B.S.

Concepts (13)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Surya Vishva Teja Jangolla's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Surya Vishva Teja Jangolla has written about over time.
Aged, 1 publications between 2024 and 2024, average publication date May 2024. Aqueous Humor, 1 publications between 2024 and 2024, average publication date May 2024. Diabetic Retinopathy, 1 publications between 2024 and 2024, average publication date May 2024. Enzyme-Linked Immunosorbent Assay, 1 publications between 2024 and 2024, average publication date May 2024. Female, 1 publications between 2024 and 2024, average publication date May 2024. Humans, 1 publications between 2024 and 2024, average publication date May 2024. Male, 1 publications between 2024 and 2024, average publication date May 2024. Middle Aged, 1 publications between 2024 and 2024, average publication date May 2024. Retina, 1 publications between 2024 and 2024, average publication date May 2024. Retinol-Binding Proteins, 1 publications between 2024 and 2024, average publication date May 2024. Severity of Illness Index, 1 publications between 2024 and 2024, average publication date May 2024. Tomography, Optical Coherence, 1 publications between 2024 and 2024, average publication date May 2024. Vitreous Body, 1 publications between 2024 and 2024, average publication date May 2024.

To see the data from this visualization as text, click here.
Jangolla's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.